硼替佐米 (Bortezomib)
硼替佐米(Bortezomib)是一种口服的、可逆的蛋白酶体抑制剂,主要应用于治疗多发性骨髓瘤。作为首个被批准用于临床治疗多发性骨髓瘤的蛋白质酶体抑制剂,硼替佐米通过特异性地结合并抑制26S蛋白酶体的功能,从而阻止受损或异常蛋白质的正常降解过程,导致这些蛋白质在细胞内累积,并最终诱导癌细胞凋亡。该药物通常以皮下注射和静脉输注两种方式给药,具体剂量需根据医生指导和患者情况调整。值得注意的是,使用硼替佐米可能引起一系列副作用,包括但不限于周围神经病变、恶心、呕吐以及低血压等,因此在用药过程中需要密切关注患者的不良反应,并采取相应措施进行管理。
欢迎咨询,我们可以为您提供该API包含的全套杂质!望知星QQ
Bortezomib Impurity R
Bortezomib Impurity R
73058-37-4
C15H15N3O3
285.29
货号品牌纯度包装库存价格数量
2317-50mg95%50mg有库存面议询单
2317-100mg95%100mg有库存面议询单
2317-250mg95%250mg有库存面议询单
2317-500mg95%500mg有库存面议询单
Bortezomib Impurity S
Bortezomib Impurity S
1446194-56-4
C19H24N4O2
340.41
货号品牌纯度包装库存价格数量
2318-50mg95%50mg有库存面议询单
2318-100mg95%100mg有库存面议询单
2318-250mg95%250mg有库存面议询单
2318-500mg95%500mg有库存面议询单
Bortezomib
Bortezomib
179324-69-7
C19H25BN4O4
384.24
货号品牌纯度包装库存价格数量
2319-50mg95%50mg有库存面议询单
2319-100mg95%100mg有库存面议询单
2319-250mg95%250mg有库存面议询单
2319-500mg95%500mg有库存面议询单
Bortezomib Impurity 70
Bortezomib Impurity 70
444576-08-3
C25H35BN4O8
530.39
货号品牌纯度包装库存价格数量
2316-50mg95%50mg有库存面议询单
2316-100mg95%100mg有库存面议询单
2316-250mg95%250mg有库存面议询单
2316-500mg95%500mg有库存面议询单
Bortezomib Impurity B
Bortezomib Impurity B
289472-81-7
C19H24N4O3
356.43
Bortezomib Impurity C
Bortezomib Impurity C
289472-80-6
C14H14N4O2
270.29
Bortezomib Impurity D
Bortezomib Impurity D
114457-94-2
C14H13N3O3
271.28
Bortezomib Impurity M
Bortezomib Impurity M
886979-78-8
C19H24N4O4
372.42
Bortezomib Impurity N
Bortezomib Impurity N
886979-81-3
C19H24N4O4
372.42
Bortezomib Impurity PS619
Bortezomib Impurity PS619
1132709-14-8
C19H25BN4O4
384.24
(1S,2R)-Bortezomib
(1S,2R)-Bortezomib
1132709-16-0
C19H25BN4O4
384.24
(1R,2R)-Bortezomib
(1R,2R)-Bortezomib
1132709-15-9
C19H25BN4O4
384.24
Bortezomib Impurity K
Bortezomib Impurity K
862895-00-9
C19H22N4O2
338.40
Bortezomib Impurity O
Bortezomib Impurity O
862894-96-0
C19H22N4O3
354.41
Bortezomib Impurity 2
Bortezomib Impurity 2
2379402-85-2
C19H22N4O4
370.40
硼替佐米杂质41
Bortezomib Impurity 40
2493017-06-2
C11H24BNO2
213.12
Bortezomib Impurity 41
Bortezomib Impurity 41
1243174-57-3
C11H25BClNO2
249.59
Bortezomib Impurity 42
Bortezomib Impurity 42
1608986-16-8
C14H13N3O3
271.27
Bortezomib Impurity 46
Bortezomib Impurity 46
1194235-41-0
C28H34BN5O5
531.41
Bortezomib Impurity 49
Bortezomib Impurity 49
4664-57-7
C11H16O3S
228.31
Bortezomib Impurity 50
Bortezomib Impurity 50
477254-68-5
C15H28BNO2
265.20
Bortezomib Impurity 51
Bortezomib Impurity 51
18680-27-8
C10H18O2
170.25
Bortezomib Impurity 52
Bortezomib Impurity 52
84110-39-4
C15H27BO2
250.18
Bortezomib Impurity 53
85167-14-2
C15H26BClO2
284.63
Bortezomib Impurity 55
Bortezomib Impurity 55
84110-34-9
C14H25BO2
236.16
Bortezomib Impurity 56
Bortezomib Impurity 56
390800-88-1
C57H69B3N12O9
1098.67
Bortezomib Impurity 57
Bortezomib Impurity 57
847644-46-6
C17H31BN2O3
322.25
Bortezomib Impurity 59
Bortezomib Impurity 59
1104011-35-9
C19H25BN4O4
384.24
Bortezomib Impurity 60
Bortezomib Impurity 60
205393-22-2
C29H39BN4O4
518.46
Bortezomib Impurity 61
Bortezomib Impurity 61
179324-87-9
C15H28BNO2.C2HF3O2
265.20 114.02
Bortezomib Impurity 65
Bortezomib Impurity 65
84110-40-7
C4H11BO2
101.94
Bortezomib Impurity 66
1173167-12-8
C15H28BNO2.HCl
265.20 36.46
(S)-BoroLeu-(-)-Pinanediol-CF3COOH
(S)-BoroLeu-(-)-Pinanediol-CF3COOH
477254-69-6
C15H28BNO2 C2HF3O2
265.20 114.02
南京望知星医药科技有限公司
VIP会员
生产研发
江苏 南京
南京六合区天圣路22号H栋6楼
廖凯
18569809817